Led by Patricia McLaughlin, professor of behavioral sciences, Penn State College of Medicine Researchers are utilizing a $200,000 grant to advance a topically applied therapy…
While insulin continues to represent a foundational treatment for diabetes patients going on a century now, the actual treatment regimen to this day represents a…
A small publicly traded Irish and American biotech called Strongbridge Biopharma plc (Nasdaq: SBBP) recently announced the results from a sub analyses of patients with…
Could diabetes-related amputations be a thing of the past? According to the results of a recent Phase 1 clinical trial now published in STEM CELLS Translational…
Juan Frias, MD, a medical director with the National Research Institute based in Los Angeles, California will present at the Endocrine Society’s annual meeting known…
In a National Institutes of Health (NIH) supported observational study, the University of Alabama at Birmingham (UAB) revealed that patients with Type 2 diabetes on…
A Novartis investigational product called Bimagrumab recently raised attention in the obesity research community. The human monoclonal antibody was designed to treat muscle loss and weakness but unfortunately…
A January 13 study published in JAMA Network Open looks at the “Effect of Bimagrumab vs. Placebo on Body Fat Mass Among Adults With Type…
Danish drug maker Novo Nordisk, a leading producer of diabetes drugs, recently announced it extended its COVID-19 Patient Assistance Program until June 30, 2021 for…
Dr. Colbey W. Freeman and colleagues in the Perelman School of Medicine at the University of Pennsylvania looked at COVID-19 patients who underwent head CT…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
